should i switch to tirzepatide from semaglutide Can you Tirzepatide? Tirzepatide vs Semaglutide: Which Weight

Working with a registered dietitian to plan nutrient-dense meals during your eating window becomes critical

The composite renal outcome (the first occurrence of new macroalbuminuria, a sustained decline in eGFR of 30% from baseline, or RRT) developed less frequently in participants using dulaglutide in comparison to those using placebo [HR 0.85 (95% CI: 0.770.93), p=0.0004]

40% were assigned female at birth and the population had mean HbA 1c of 8.1%, BMI of 35.3 kg/m 2 , (Table 1)

Phase 2 trial data (NEJM, 2023) showed promising weight reduction results, but long-term safety and cardiovascular outcomes remain under investigation in ongoing Phase 3 trials

Most patients see the difference within 3-6 months, with optimal results coming in around 6-8 months later

While empagliflozin primarily targets blood sugar control and cardiovascular risks, its direct impact on reducing diabetes-related blindness is less straightforward